Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,247 | Dovepress* | 11,849+ | 1,561 | 13,410 | |
| PubMed Central* | 1,398 | 516 | 1,914 | ||
| Totals | 13,247 | 2,077 | 15,324 | ||
| *Since 10 November 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar